BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21347310)

  • 1. The RACK1 signaling scaffold protein selectively interacts with Yersinia pseudotuberculosis virulence function.
    Thorslund SE; Edgren T; Pettersson J; Nordfelth R; Sellin ME; Ivanova E; Francis MS; Isaksson EL; Wolf-Watz H; Fällman M
    PLoS One; 2011 Feb; 6(2):e16784. PubMed ID: 21347310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.
    Holmström A; Petterson J; Rosqvist R; Håkansson S; Tafazoli F; Fällman M; Magnusson KE; Wolf-Watz H; Forsberg A
    Mol Microbiol; 1997 Apr; 24(1):73-91. PubMed ID: 9140967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
    Francis MS; Wolf-Watz H
    Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence plasmid-encoded YopK is essential for Yersinia pseudotuberculosis to cause systemic infection in mice.
    Holmström A; Rosqvist R; Wolf-Watz H; Forsberg A
    Infect Immun; 1995 Jun; 63(6):2269-76. PubMed ID: 7768608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Yersinia Yop-effector delivery by translocated YopE.
    Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
    Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity.
    Håkansson S; Schesser K; Persson C; Galyov EE; Rosqvist R; Homblé F; Wolf-Watz H
    EMBO J; 1996 Nov; 15(21):5812-23. PubMed ID: 8918459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yersinia controls type III effector delivery into host cells by modulating Rho activity.
    Mejía E; Bliska JB; Viboud GI
    PLoS Pathog; 2008 Jan; 4(1):e3. PubMed ID: 18193942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
    Zwack EE; Feeley EM; Burton AR; Hu B; Yamamoto M; Kanneganti TD; Bliska JB; Coers J; Brodsky IE
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
    Viboud GI; So SS; Ryndak MB; Bliska JB
    Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TyeA of Yersinia pseudotuberculosis is involved in regulation of Yop expression and is required for polarized translocation of Yop effectors.
    Sundberg L; Forsberg A
    Cell Microbiol; 2003 Mar; 5(3):187-202. PubMed ID: 12614462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells.
    Edqvist PJ; Aili M; Liu J; Francis MS
    Microbes Infect; 2007 Feb; 9(2):224-33. PubMed ID: 17223369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
    Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
    mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
    Sheahan KL; Isberg RR
    mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
    Adams W; Morgan J; Kwuan L; Auerbuch V
    Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type III secretion translocon assemblies that attenuate Yersinia virulence.
    Costa TR; Amer AA; Farag SI; Wolf-Watz H; Fällman M; Fahlgren A; Edgren T; Francis MS
    Cell Microbiol; 2013 Jul; 15(7):1088-110. PubMed ID: 23279117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis.
    Frithz-Lindsten E; Holmström A; Jacobsson L; Soltani M; Olsson J; Rosqvist R; Forsberg A
    Mol Microbiol; 1998 Sep; 29(5):1155-65. PubMed ID: 9767584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type III secretion system-dependent translocation of ectopically expressed Yop effectors into macrophages by intracellular Yersinia pseudotuberculosis.
    Zhang Y; Romanov G; Bliska JB
    Infect Immun; 2011 Nov; 79(11):4322-31. PubMed ID: 21844228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coiled-coils in the YopD translocator family: a predicted structure unique to the YopD N-terminus contributes to full virulence of Yersinia pseudotuberculosis.
    Costa TR; Amer AA; Fällman M; Fahlgren A; Francis MS
    Infect Genet Evol; 2012 Dec; 12(8):1729-42. PubMed ID: 22910185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Amino-Terminal Part of the Needle-Tip Translocator LcrV of
    Ekestubbe S; Bröms JE; Edgren T; Fällman M; Francis MS; Forsberg Å
    Front Cell Infect Microbiol; 2016; 6():175. PubMed ID: 27995096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yersinia pestis YopK Inhibits Bacterial Adhesion to Host Cells by Binding to the Extracellular Matrix Adaptor Protein Matrilin-2.
    Tan Y; Liu W; Zhang Q; Cao S; Zhao H; Wang T; Qi Z; Han Y; Song Y; Wang X; Yang R; Du Z
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28533472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.